 |
PDBsum entry 3fby
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pore analysis for: 3fby calculated with  MOLE 2.0
|
PDB id
|
|
|
|
3fby
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pores calculated on whole structure |
|
Pores calculated excluding ligands
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
17 pores,
coloured by radius |
|
28 pores,
coloured by radius
|
28 pores,
coloured as in
list below
|
|
|
|
|
|
Pores are connected internal spaces going through the structure. Only pores longer than 25 Å are shown. |
|
|
|
|
|
|
|
Free R
|
|
|
|
|
|
|
Length
|
|
|
|
|
|
|
HPathy
|
|
|
|
|
|
|
HPhob
|
|
|
|
|
|
|
Polar
|
|
|
|
|
|
|
Rel Mut
|
|
|
|
|
|
|
Residue..type
|
|
|
|
|
|
|
Ligands
|
|
|
|
|
|
|
 |
Radius |
 |
1 |
 |
3.10 |
4.11 |
27.5 |
-1.27 |
0.01 |
23.9 |
84 |
|
4 |
1 |
3 |
4 |
0 |
1 |
0 |
|
SO4 1001 A SO4 1003 A NAG 1 D NAG 2 D MAN 3 D
|
 |
|
2 |
 |
3.08 |
3.90 |
27.7 |
-0.43 |
-0.27 |
12.9 |
86 |
2 |
3 |
3 |
4 |
0 |
1 |
0 |
SO4 1001 C SO4 1003 C NAG 1 F NAG 2 F MAN 3 F
|
|
3 |
 |
2.97 |
4.86 |
34.7 |
-0.32 |
-0.15 |
3.3 |
80 |
1 |
0 |
4 |
5 |
2 |
1 |
0 |
|
|
4 |
 |
2.87 |
4.93 |
39.0 |
-0.85 |
-0.27 |
7.9 |
77 |
1 |
3 |
5 |
4 |
3 |
1 |
0 |
|
|
5 |
 |
1.50 |
2.07 |
40.8 |
-0.97 |
-0.40 |
16.9 |
84 |
3 |
4 |
2 |
3 |
1 |
0 |
1 |
|
|
6 |
 |
2.14 |
2.42 |
41.1 |
-1.95 |
-0.68 |
22.9 |
78 |
6 |
2 |
0 |
0 |
0 |
1 |
0 |
|
|
7 |
 |
1.53 |
2.05 |
50.8 |
-1.08 |
-0.45 |
17.1 |
86 |
4 |
4 |
3 |
3 |
1 |
0 |
1 |
|
|
8 |
 |
2.38 |
2.77 |
55.4 |
-2.06 |
-0.41 |
27.4 |
84 |
6 |
3 |
3 |
3 |
1 |
1 |
0 |
SO4 1001 A NAG 1 D
|
|
9 |
 |
2.44 |
2.68 |
55.5 |
-1.75 |
-0.52 |
18.2 |
82 |
7 |
2 |
4 |
5 |
1 |
0 |
0 |
|
|
10 |
 |
2.17 |
2.17 |
56.2 |
-1.56 |
-0.49 |
20.6 |
89 |
4 |
4 |
5 |
4 |
0 |
1 |
0 |
NAG 1 F
|
|
11 |
 |
2.45 |
2.68 |
62.2 |
-2.84 |
-0.48 |
32.3 |
82 |
6 |
2 |
3 |
1 |
0 |
1 |
0 |
|
|
12 |
|
3.48 |
3.48 |
62.7 |
-1.55 |
-0.46 |
16.1 |
82 |
5 |
2 |
4 |
6 |
1 |
0 |
0 |
|
|
13 |
|
2.44 |
2.67 |
65.0 |
-1.35 |
-0.29 |
17.2 |
81 |
6 |
4 |
6 |
5 |
1 |
1 |
0 |
|
|
14 |
|
2.44 |
2.67 |
65.1 |
-1.72 |
-0.43 |
18.2 |
81 |
7 |
3 |
7 |
4 |
1 |
1 |
0 |
|
|
15 |
|
2.82 |
4.93 |
67.8 |
-1.34 |
-0.28 |
15.9 |
82 |
4 |
3 |
7 |
5 |
1 |
1 |
0 |
|
|
16 |
|
2.12 |
2.42 |
67.8 |
-2.62 |
-0.52 |
30.2 |
81 |
6 |
3 |
2 |
1 |
0 |
1 |
0 |
|
|
17 |
|
2.91 |
4.93 |
72.1 |
-1.09 |
-0.18 |
15.7 |
81 |
4 |
4 |
6 |
6 |
1 |
1 |
0 |
|
|
18 |
|
3.48 |
3.48 |
77.9 |
-1.86 |
-0.53 |
19.6 |
80 |
6 |
2 |
3 |
6 |
1 |
1 |
0 |
|
|
19 |
|
2.92 |
4.90 |
87.3 |
-1.43 |
-0.27 |
18.6 |
79 |
5 |
4 |
5 |
5 |
1 |
2 |
0 |
|
|
20 |
|
2.86 |
5.00 |
87.4 |
-1.81 |
-0.43 |
19.8 |
79 |
6 |
3 |
6 |
4 |
1 |
2 |
0 |
|
|
21 |
|
2.17 |
2.48 |
94.6 |
-1.97 |
-0.47 |
23.0 |
77 |
8 |
5 |
3 |
5 |
2 |
1 |
0 |
|
|
22 |
|
3.06 |
4.07 |
31.0 |
-1.20 |
-0.07 |
25.2 |
87 |
4 |
2 |
2 |
4 |
0 |
0 |
0 |
SO4 1002 B NAG 1 E
|
|
23 |
|
3.29 |
5.78 |
35.6 |
-0.76 |
0.09 |
24.6 |
81 |
4 |
5 |
3 |
4 |
1 |
1 |
0 |
SO4 1002 B NAG 1 E NAG 2 E MAN 3 E
|
|
24 |
|
1.68 |
1.86 |
60.7 |
-2.01 |
-0.70 |
28.1 |
84 |
4 |
9 |
3 |
3 |
2 |
0 |
0 |
CA 816 B
|
|
25 |
|
1.86 |
2.17 |
73.2 |
-1.28 |
-0.48 |
15.2 |
79 |
4 |
5 |
3 |
5 |
3 |
1 |
0 |
CA 816 B
|
|
26 |
|
1.60 |
1.60 |
81.7 |
-1.85 |
-0.48 |
27.5 |
83 |
6 |
10 |
3 |
3 |
0 |
1 |
0 |
NAG 1 E NAG 2 E MAN 3 E
|
|
27 |
|
1.61 |
1.61 |
86.0 |
-1.44 |
-0.28 |
28.2 |
81 |
7 |
7 |
2 |
5 |
0 |
0 |
0 |
SO4 1002 B
|
 |
28 |
|
1.53 |
2.64 |
35.8 |
-1.86 |
-0.64 |
28.6 |
91 |
3 |
5 |
3 |
2 |
0 |
0 |
0 |
CA 816 A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
Residue-type_colouring |
 |
|
|
|
Positive
|
Negative
|
Neutral
|
Aliphatic
|
Aromatic
|
Pro & Gly
|
Cysteine
|
|
H,K,R
|
D,E
|
S,T,N,Q
|
A,V,L,I,M
|
F,Y,W
|
P,G
|
C
|
|
|
|
MOLE 2.0 program